Repaglinide
NDC 33342-249, Repaglinide, tablet, from Macleods Pharmaceuticals Limited.
- Product NDC
- 33342-249
- Status
- Listed
- Labeler
- Macleods Pharmaceuticals Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207209
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/33342-249 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REPAGLINIDE1 mg/1
Pharmacologic classes
Glinide [EPC]; Potassium Channel Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 33342-249-11 | 33342024911 | 100 TABLET in 1 BOTTLE (33342-249-11) |
| 33342-249-44 | 33342024944 | 1000 TABLET in 1 BOTTLE (33342-249-44) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7a93246c-9323-40c4-b590-a40dcb133c8cNADAC price for package 33342024911
GET /v1/drugs/nadac/33342024911
Use it
Look up 33342-249 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/33342-249 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 33342-249. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.